Simmaron’s Rapamycin ME/CFS Trial Moves Forward: The Goal – FDA Approval
A successful rapamycin clinical trial in chronic fatigue syndrome (ME/CFS) leads to more studies and perhaps FDA approval
A “Scarred Landscape” … Epigenetic T-Cell Study Moves the ME/CFS Field Forward
Evidence indicating that the T-cells in ME/CFS are exhausted could lead to new treatment options.
“What’s Up, Doc?” Nancy Klimas on Viruses, ME/CFS’s Greatest Need, and Her ME/CFS Clinical Trial
Dr. Nancy Klimas says what's exciting her most right now in the ME/CFS field is a renewed focus on herpesvirus reactivation and what artificial intelligence will bring.
Another Balky Metabolic Pathway in ME/CFS? The Pentose Pathway, Low Oxygen, Blood Vessel, and Even Neuroinflammation Connection
What’s going on in orthostatic intolerance (symptoms triggered by standing or sitting up) has been well described – from the outside. We can see heart rates go up (postural orthostatic tachycardia syndrome (POTS))…
Jen’s Rinvoq ME/CFS Recovery Pt. II: JAK Inhibitors in ME/CFS and Long COVID
Jen X’s remarkable and full recovery from a long-term case of severe ME/CFS using Rinvoq, otherwise known as upadacitinib, has put it and the other “citinib” drugs in the spotlight. This blog takes a deeper dive into what happened and what’s going on with these drugs…
Lives Interrupted Latest Story
Megan
Randolph, United States
Former occupation: Day care worker
$562,824
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
